In the multivariate analysis, we found that the baseline AFP ≥ 400 ng/ml and initial tumor shape irregularity were both significant independent factors predicting the prognosis of patients with HCC undergoing immunotherapy. The gene discussed is AFP; the disease is hepatocellular carcinoma.